XML 50 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment information (Tables)
9 Months Ended
Sep. 30, 2022
Segment information  
Schedule of segments

    

Diagnostics

    

Therapeutics

    

Consolidated

Net revenue

$

242

$

12,531

$

12,773

Cost of revenue

 

149

 

3,266

 

3,415

Gross profit (loss)

$

93

$

9,265

$

9,358